1. Home
  2. PTLE vs PMCB Comparison

PTLE vs PMCB Comparison

Compare PTLE & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTLE
  • PMCB
  • Stock Information
  • Founded
  • PTLE 2013
  • PMCB 1996
  • Country
  • PTLE Singapore
  • PMCB United States
  • Employees
  • PTLE N/A
  • PMCB N/A
  • Industry
  • PTLE Oil Refining/Marketing
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PTLE Energy
  • PMCB Health Care
  • Exchange
  • PTLE Nasdaq
  • PMCB Nasdaq
  • Market Cap
  • PTLE 6.1M
  • PMCB 6.6M
  • IPO Year
  • PTLE 2024
  • PMCB N/A
  • Fundamental
  • Price
  • PTLE $0.16
  • PMCB $0.99
  • Analyst Decision
  • PTLE
  • PMCB
  • Analyst Count
  • PTLE 0
  • PMCB 0
  • Target Price
  • PTLE N/A
  • PMCB N/A
  • AVG Volume (30 Days)
  • PTLE 3.9M
  • PMCB 55.6K
  • Earning Date
  • PTLE 01-01-0001
  • PMCB 12-12-2025
  • Dividend Yield
  • PTLE N/A
  • PMCB N/A
  • EPS Growth
  • PTLE N/A
  • PMCB N/A
  • EPS
  • PTLE N/A
  • PMCB 0.01
  • Revenue
  • PTLE $98,133,646.00
  • PMCB N/A
  • Revenue This Year
  • PTLE N/A
  • PMCB N/A
  • Revenue Next Year
  • PTLE N/A
  • PMCB N/A
  • P/E Ratio
  • PTLE N/A
  • PMCB $155.21
  • Revenue Growth
  • PTLE N/A
  • PMCB N/A
  • 52 Week Low
  • PTLE $0.14
  • PMCB $0.80
  • 52 Week High
  • PTLE $15.78
  • PMCB $2.42
  • Technical
  • Relative Strength Index (RSI)
  • PTLE 45.77
  • PMCB 47.44
  • Support Level
  • PTLE $0.15
  • PMCB $0.94
  • Resistance Level
  • PTLE $0.17
  • PMCB $1.00
  • Average True Range (ATR)
  • PTLE 0.01
  • PMCB 0.05
  • MACD
  • PTLE -0.00
  • PMCB -0.01
  • Stochastic Oscillator
  • PTLE 33.00
  • PMCB 29.69

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, serving the Asia Pacific market. The company's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers on time; and handling disputes, mainly concerning quality and quantity issues on marine fuel. The company derives its maximum revenue from Hong Kong.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Share on Social Networks: